Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease

S. Kumar, R. C. Wolf, M. G. Chen, D. A. Gastineau, M. A. Gertz, D. J. Inwards, M. Q. Lacy, A. Tefferi, M. R. Litzow

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint Dive into the research topics of 'Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease'. Together they form a unique fingerprint.

Medicine & Life Sciences